Quest Diagnostics Inc (DGX) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access DGX quarterly Cash Flow →
Cash flow performance over multiple periods helps investors evaluate the stability of Quest Diagnostics Inc's cash-generating activities.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
12 Months
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income1,046.00
Depreciation & amortization570.00
Amortization of Other Assets0.00
Extraordinary loss0.00
Restructuring charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
Acquisition of in process R & D0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation88.00
Minority interests0.00
Tax benefit on stock options0.00
Provision For Special Charges-
Gainon Sale of Royalty Rights-
Accounts Receivable-
Gain Loss On Disposition Of Joint Venture-
Contract With Customer Asset Credit Loss Expense3.00
Income taxes129.00
Gain (Loss) on Sale of Investments0.00
Increase (Decrease) in Accounts Receivable-106.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities129.00
Accrued restructuring costs0.00
Deferred income0.00
Prepaid expenses0.00
Other Working Capital3.00
Other Noncash Income (Expense)24.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities1,886.00
Investing Activities
Capital Expenditures-527.00
Sale of Capital Items0.00
Short-term investments liq.0.00
Short-term investments acq.0.00
Proceeds from other investments0.00
Proceeds from Divestiture of Royalty Rights-
Decrease in Restricted Cash0.00
Noncontrolling interest0.00
Proceeds from Investments0.00
Purchases of Investments0.00
Purchases of non-current assets0.00
Payments to Acquire Businesses, Net of Cash Acquired-101.00
Proceeds from Sale of Equity Method Investments0.00
Sale of businesses0.00
Proceeds from sale of assets0.00
Note receivable0.00
Payments for (Proceeds from) Other Investing Activities-3.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-631.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings-602.00
Long-term debt - repayments0.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock-371.00
Exercise of stock options0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net0.00
Other net-555.00
Proceeds From Borrowings-
Paymentofdeferredbusinessacquisitionconsideration-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents549.00
Payments of Ordinary Dividends, Noncontrolling Interest-56.00
Dividends paid-353.00
Net Cash Flow from Financing Activities-1,388.00
Effect of exchange rate on cash flow4.00
Discontinued operations0.00
Free Cash Flow1,359.00
Total Cash Flow-129.00
4 historic quarters locked

Sign in to unlock the full Quest Diagnostics Inc cash flow history.

About Quest Diagnostics Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: dgx-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001022079-26-000015

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document





                    
Get the full CSIMarket dataset: Subscribe API License